Skip to main navigation
Skip to search
Skip to main content
University of East Anglia Home
Home
People
Organisations
Research output
Projects
Datasets
Prizes
Activities
Press/Media
Impacts
Search by expertise, name or affiliation
Developing a new targeted therapy for treatment of metastic prostate cancer: synthesis and preclinical validation of sphingosine inhibitor-docetaxel combination nanoparticles
Cooper, Colin
(Principal Investigator)
Pshezhetskiy, Dmitry
(Co-Investigator)
Norwich Medical School
Cancer Studies
Overview
Research output
(2)
Research output
Research output per year
2017
2017
2017
2
Article
Research output per year
Research output per year
2 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Search results
2017
Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1
Alshaker, H.
,
Wang, Q.
,
Böhler, T.
,
Mills, R.
,
Winkler, M.
,
Arafat, T.
,
Kawano, Y.
&
Pchejetski, D.
,
14 Jun 2017
,
In:
Scientific Reports.
7
, 3493.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
22
Citations (Scopus)
10
Downloads (Pure)
Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
Wang, Q.
,
Alshaker, H.
,
Böhler, T.
,
Srivats, S.
,
Chao, Y.
,
Cooper, C.
&
Pchejetski, D.
,
19 Jul 2017
,
In:
Scientific Reports.
7
, 5901.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
55
Citations (Scopus)
27
Downloads (Pure)